Growth of patients with 21-hydroxylase deficiency: An analysis of the factors influencing adult height

Pediatric Research

Volumn 41, Issue 1, 1997, Pages 30-33

  Jääskeläinen, Jarmo ^a   Voutilainen, Raimo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; STEROID 21 MONOOXYGENASE;

ADULT; ARTICLE; BODY HEIGHT; BONE GROWTH; CORTICOSTEROID THERAPY; EARLY DIAGNOSIS; FEMALE; FINLAND; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PUBERTY; STEROID 21 MONOOXYGENASE DEFICIENCY;

EID: 4243223297     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-199701000-00005     Document Type: Article

References (19)

1. Young MC, Ribeiro J, Hughes IA 1989 Growth and body proportions in congenital adrenal hyperplasia. Arch Dis Child 64:1554-1558
2. Yu ACM, Grant DB 1995 Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood. Acta Paediatr 84:899-903
3. DiMartino-Nardi, Stoner E, O'Connell A, New MI 1986 The effect of treatment on final height in classical congenital adrenal hyperplasia treated with hydrocortisone. Acta Endocrinol 279(suppl):305-314
4. Urban MD, Lee PA, Migeon CJ 1978 Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N Engl J Med 299:1392-1396
5. Klingensmith GJ, Garcia SC, Jones Jr HW, Migeon CJ, Blizzard RM 1977 Glucocorticoid treatment of girls with congenital adrenal hyperplasia: Effects on height, sexual maturation, and fertility. J Pediatr 90:996-1004
6. Brook CGD, Zachmann M, Prader A, Murset G 1974 Experience with long-term therapy in congenital adrenal hyperplasia. J Pediatr 85:12-19
7. Appan S, Hindmarsh PC, Brook CGD 1989 Monitoring treatment in congenital adrenal hyperplasia. Arch Dis Child 64:1235-1239
8. Brook CGD 1990 The management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol 33:559-567
9. Aceto T, MacGillivray MH, Caprano VJ, Munschauer RV, Raiti S 1966 Congenital virilizing adrenal hyperplasia without acceleration of growth or bone maturation. JAMA 198:91-94
10. Thilen A, Woods KA, Perry LA, Savage MO, Wedell A, Ritzen EM 1995 Early growth is not increased in untreated moderately severe 21-hydroxylase deficiency. Acta Paediatr 84:894-898
11. Miller WL. Clinical review 54 1994 Genetics, diagnosis and management of 21-hydroxylase deficiency. J Clin Endocrinol Metab 78:241-246
12. Sorva R, Perheentupa J, Tolppanen EM 1984 A novel format for a growth chart. Acta Paediatr Scand 73:527-529
13. Sorva R, Tolppanen EM, Lankinen S, Perheentupa J 1989 Growth evaluation: parent and child specific height standards. Arch Dis Child 64:1483-1487
14. Pere A, Perheentupa J, Peter M, Voutilainen R 1995 Follow up of growth and steroids in premature adrenarche. Eur J Pediatr 154:346-352
15. Clayton GW 1986 Patterns of growth from birth to maturity in infants and children with congenital adrenal hyperplasia. Acta Endocrinol 279(suppl):295-304
16. Young MC, Hughes IA 1990 Response to treatment of congenital adrenal hyperplasia in infancy. Arch Dis Child 65:441-444
17. Greylich WW, Pyle SI 1959 Radiographic Atlas of Skeletal Development of the Hand and Wrist, Ed 2. Stanford University Press, Stanford, pp 62-179
18. Marshall WA, Tanner JM 1969 Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-294
19. Marshall WA, Tanner JM 1970 Variation in the pattern of pubertal changes in boys. Arch Dis Child 45:13-16